1. Tasian, G, Ross, M, Song, L, et al. Annual incidence of nephrolithiasis among children and adults in South Carolina from 1997 to 2012. Clin J Am Soc Nephrol 2016; 11: 488–496.
Google Scholar | Crossref | Medline2. Dwyer, M, Krambeck, A, Bergstralh, E, et al. Temporal trends in incidence of kidney stones among children: a 25-year population based study. J Urol 2012; 188: 247–252.
Google Scholar | Crossref | Medline | ISI3. Sas, DJ, Hulsey, TC, Shatat, IF, et al. Incidence of kidney stones in children evaluated in the ER is increasing. J Pediatr 2010; 157: 132–137.
Google Scholar | Crossref | Medline | ISI4. Rajeshwari, R, Yang, S, Nicklas, T, et al. Secular trends in children’s sweetened-beverage consumption (1973 to 1994): the Bogalusa heart study. J Am Diet Assoc 2005; 105: 208–214.
Google Scholar | Crossref | Medline5. Fakheri, RJ, Goldfarb, DS. Ambient temperature as a contributor to kidney stone formation: implications of global warming. Kidney Int 2011; 79: 1178–1185.
Google Scholar | Crossref | Medline | ISI6. Issler, N, Dufek, S, Kleta, R, et al. Epidemiology of paediatric renal stone disease: a 22-year single centre experience in the UK. BMC Nephrol 2017; 18: 136.
Google Scholar | Crossref | Medline7. Strauss, S, Waltuch, T, Bivin, W, et al. Primary hyperoxaluria: spectrum of clinical and imaging findings. Pediatr Radiol 2017; 47: 96–103.
Google Scholar | Crossref | Medline8. Daudon, M, Frochot, V, Bazin, D, J, et al. Drug-induced kidney stones and crystalline nephropathy: pathophysiology, prevention and treatment. Drugs 2018; 78: 163–201.
Google Scholar | Crossref | Medline9. Kairam, N, Allegra, J, Eskin, B. Rise in emergency department visits of pediatric patients for renal colic from 1999 to 2008. Pediatr Emerg Care 2013; 29: 462–464.
Google Scholar | Crossref | Medline | ISI10. Milliner, DS, Murphy, ME. Urolithiasis in pediatric patients. Mayo Clin Proc 1993; 68: 241–248.
Google Scholar | Crossref | Medline11. Korˇvara, R, Plasgura, P, Petrˇík, A, et al. A prospective study of nonmedical prophylaxis after a first kidney stone. BJU Int 1999; 84: 393–398.
Google Scholar | Crossref | Medline12. Pearle, M, Goldfarb, D, Assimos, D, et al. Medical management of kidney stones: AUA guideline. J Urol 2014; 192: 316–324.
Google Scholar | Crossref | Medline | ISI13. Gouru, V, Pogula, V, Vaddi, S, et al. Metabolic evaluation of children with urolithiasis. Urol Ann 2018; 10: 94–99.
Google Scholar | Crossref | Medline14. Hernandez, J, Ellison, J, Lendvay, T. Current trends, evaluation, and management of pediatric nephrolithiasis. JAMA Pediatr 2015; 169: 964–970.
Google Scholar | Crossref | Medline | ISI15. Heilberg, I, Goldfarb, D. Optimum nutrition for kidney stone disease. Adv Chronic Kidney Dis 2013; 20: 165–174.
Google Scholar | Crossref | Medline | ISI16. Wigertz, K, Palacios, C, Jackman, L, et al. Racial differences in calcium retention in response to dietary salt in adolescent girls. Am J Clin Nutr 2005; 81: 845–850.
Google Scholar | Crossref | Medline | ISI17. Nouvenne, A, Meschi, T, Prati, B, et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr 2010; 91: 565–570.
Google Scholar | Crossref | Medline | ISI18. US Department of Health and Human Services . 2015–2020 dietary guidelines for Americans. Washington, DC: US Department of Health and Human Services; US Department of Agriculture, 2015.
Google Scholar19. Institute of Medicine . Dietary reference intakes: the essential guide to nutrient requirements. Otten, JJ, Hellwig, JP, Meyers, LD (eds). Washington, DC: The National Academies Press, 2006.
Google Scholar20. Curhan, G, Willett, W, Rimm, E, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993; 328: 833–838.
Google Scholar | Crossref | Medline | ISI21. Panzarino, V. Urolithiasis in children. Adv Pediatr 2020; 67:105–112.
Google Scholar | Crossref | Medline22. Borghi, L, Schianchi, T, Meschi, T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002; 346: 77–84.
Google Scholar | Crossref | Medline | ISI23. Sas, D, Becton, L, Tutman, J, et al. Clinical, demographic, and laboratory characteristics of children with nephrolithiasis. Urolithiasis 2016; 44: 241–246.
Google Scholar | Crossref | Medline24. Spivacow, F, Negri, A, del Valle, E, et al. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 2008; 23: 1129–1133.
Google Scholar | Crossref | Medline | ISI25. Matos, V, Van Melle, G, Boulat, O, et al. Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population. J Pediatr 1997; 131: 252–257.
Google Scholar | Crossref | Medline | ISI26. Choi, J, Lee, J, Shin, J. Low-dose thiazide diuretics in children with idiopathic renal hypercalciuria. Acta Paediatr 2011; 100: e71–e74.
Google Scholar | Crossref | Medline27. Neuhaus, T, Belzer, T, Blau, N, et al. Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child 2000; 82: 322–326.
Google Scholar | Crossref | Medline28. VanDervoort, K, Wiesen, J, Frank, R, et al. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 2007; 177: 2300–2305.
Google Scholar | Crossref | Medline | ISI29. Matos, V, Van Melle, G, Werner, D, et al. Urinary oxalate and urate to creatinine ratios in a healthy pediatric population. Am J Kidney Dis 1999; 34: e1.
Google Scholar | Crossref | Medline30. Penido, MG, Srivastava, T, Alon, US. Pediatric primary urolithiasis: 12-year experience at a Midwestern Children’s Hospital. J Urol 2013; 189: 1493–1497.
Google Scholar | Crossref | Medline | ISI31. Sas, D, Harris, P, Milliner, D. Recent advances in the identification and management of inherited hyperoxalurias. Urolithiasis 2019; 47: 79–89.
Google Scholar | Crossref | Medline32. Assimos, D. Re: Oxalate content of food: a tangled web. J Urol 2015; 193: 897.
Google Scholar33. Kirejczyk, J, Porowski, T, Konstantynowicz, J, et al. Urinary citrate excretion in healthy children depends on age and gender. Pediatr Nephrol 2014; 29: 1575–1582.
Google Scholar | Crossref | Medline34. Khan, S, Pearle, M, Robertson, W, et al. Kidney stones. Nat Rev Dis Primers 2017; 3: 17001.
Google Scholar | Crossref | Medline35. Kern, A, Grimsby, G, Mayo, H, et al. Medical and dietary interventions for preventing recurrent urinary stones in children. Cochrane Database Syst Rev 2017; 11: CD011252.
Google Scholar | Medline36. Kittanamongkolchai, W, Mara, K, Mehta, R, et al. Risk of hypertension among first-time symptomatic kidney stone formers. Clin J Am Soc Nephrol 2017; 12: 476–482.
Google Scholar | Crossref | Medline37. Pfau, A, Knauf, F. Update on nephrolithiasis: core curriculum 2016. Am J Kidney Dis 2016; 68: 973–985.
Google Scholar | Crossref | Medline38. Taylor, E, Curhan, G. Fructose consumption and the risk of kidney stones. Kidney Int 2008; 73: 207–212.
Google Scholar | Crossref | Medline | ISI39. Sarica, K, Erturhan, S, Yurtseven, C, et al. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children. J Endourol 2006; 20: 875–879.
Google Scholar | Crossref | Medline40. Pearle, MS, Asplin, JR, Coe, FL, et al. Medical management of urolithiasis. In: Denstedt, J, Khoury, S (eds) Stone disease. Health Publications, http://www.icud.info/PDFs/Stone-Disease.pdf#page=56 (2008)
Google Scholar41. Barcelo, P, Wuhl, O, Servitge, E, et al. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993; 150: 1761–1764.
Google Scholar | Crossref | Medline42. Skolarikos, A, Straub, M, Knoll, T, et al. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol 2015; 67: 750–763.
Google Scholar | Crossref | Medline43. Favus, MJ, Coe, FL. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Scand J Urol Nephrol Suppl 1980; 53: 265–271.
Google Scholar | Medline44. Ettinger, B, Tang, A, Citron, JT, et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986; 315: 1386–1389.
Google Scholar | Crossref | Medline45. von Unruh, GE, Voss, S, Sauerbruch, T, et al. Dependence of oxalate absorption on the daily calcium intake. J Am Soc Nephrol 2004; 15: 1567–1573.
Google Scholar | Crossref | Medline46. Fink, HA, Akornor, JW, Garimella, PS, et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol 2009; 56: 72–80.
Google Scholar | Crossref | Medline47. Prien, EL, Gershoff, SF. Magnesium oxide-pyridoxine therapy for recurrent calcium oxalate calculi. J Urol 1974; 112: 509–512.
Google Scholar | Crossref | Medline48. Gil-Pena, H, Mejia, N, Santos, F. Renal tubular acidosis. J Pediatr 2014; 164: 691–698.e1.
Google Scholar | Crossref | Medline49. Weigert, A, Hoppe, B. Nephrolithiasis and nephrocalcinosis in childhood-risk factor-related current and future treatment options. Front Pediatr 2018; 6: 98.
Google Scholar | Crossref | Medline50. Kurita, Y, Kageyama, S, Ishikawa, A, et al. [Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria]. Hinyokika Kiyo 1994; 40: 479–483.
Google Scholar | Medline51. Pak, CY, Fuller, C, Sakhaee, K, et al. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol 1986; 136: 1003–1008.